KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueGoodwillGoodwill & IntangiblesIntangiblesLiabilities and Shareholders EquityLong-Term Deferred TaxNon-Current AssetsNon-Current Deferred Tax LiabilityOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShares OutstandingTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Medpace Holdings (MEDP) Operating Leases (2019 - 2025)

Medpace Holdings (MEDP) has disclosed Operating Leases for 7 consecutive years, with $124.9 million as the latest value for Q2 2025.

  • For the quarter ending Q2 2025, Operating Leases changed N/A year-over-year to $124.9 million, compared with a TTM value of $124.9 million through Jun 2025, changed N/A, and an annual FY2024 reading of $126.2 million, down 11.18% over the prior year.
  • Operating Leases was $124.9 million for Q2 2025 at Medpace Holdings, down from $126.2 million in the prior quarter.
  • Across five years, Operating Leases topped out at $158.1 million in Q4 2022 and bottomed at $124.9 million in Q2 2025.
  • Average Operating Leases over 5 years is $138.7 million, with a median of $137.7 million recorded in 2022.
  • The sharpest move saw Operating Leases rose 20.75% in 2022, then decreased 11.18% in 2024.
  • Year by year, Operating Leases stood at $131.0 million in 2021, then increased by 20.75% to $158.1 million in 2022, then fell by 10.13% to $142.1 million in 2023, then dropped by 11.18% to $126.2 million in 2024, then dropped by 1.02% to $124.9 million in 2025.
  • Business Quant data shows Operating Leases for MEDP at $124.9 million in Q2 2025, $126.2 million in Q4 2024, and $151.9 million in Q3 2024.